NSE · INDOUS

Indo Us Biotech Limited

Sector: Healthcare · ISIN: INE250Z01010

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#2,619

of 5,096 stocks

▼ 41W

Peak #2,615 · 21 Sep 2026

Operating in Healthcare, Indo Us Biotech Limited trades at an undemanding earnings multiple, remains firmly promoter-controlled, with promoters holding 68%, and is growing revenue modestly. Ownership as of Jun 2026.

Market Cap

156.21 Cr

P/E Ratio

11.91

P/B Ratio

1.69

ROE

14.18%

ROCE

17.27%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	32.99 Cr	26.02 Cr	22.80 Cr	30.85 Cr
Net Profit	3.04 Cr	1.97 Cr	3.00 Cr	3.45 Cr
EPS	1.51	0.98	1.49	1.72
Operating Profit	3.82 Cr	2.98 Cr	3.93 Cr	3.98 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

68.29%

Public

31.71%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
03 Dec 2024	Dividend	Interim Dividend - Rs 0.25 Per Share

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs